Meeting 2: Commitee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic
Meeting Two of the committee took place on Januray 7, 2008 at the Keck Center of the National Academies, 500 5th Street, NW, Washington, DC 20001, room 110.
Available speaker PowerPoint presentations can be found at the bottom of this webpage.
AGENDA
January 7, 2008
10:00 am
Influenza antivirals and their use: effectiveness, resistance, surveillance
Alexander Klimov
Chief, Virus Surveillance and Diagnosis Branch
Influenza Division
Centers for Disease Control and Prevention
10:20 am
Mathematical modeling of resistance in a pandemic
Marc Lipsitch
Professor of Epidmiology
Department of Epidemiology
Department of Immunology and Infectious Diseases
Harvard School of Public Health
10:40 am
Committee questions and discussion
11:00 am
Antiviral distribution planning: more from state public health agencies
Paul Jarris
Executive Director
Association of State and Territorial Health Officials
11:15 am
Committee questions and discussion
11:30 am
Lessons from past public health drug or vaccine distribution campaigns: swine flu immunization program, antibiotic distributuion after anthrax attacks, vaccine shortage
- Swine flu
Walter Dowdle
Senior Consultant to WHO
Polio Eradication Program
Task Force on Child Survival and Development
11:45 am
Lunch
12:45 pm
Lessons from past public health drug or vaccine distribution campaigns, continued
- Influenza vaccine shortage
Claire Hannan
Executive Director
Association of Immunization Managers
- Anthrax
Eddy Bresnitz
Deputy Health Commissioner
State Epidemiologist
New Jersey
Mary Mahoney
Bioterrorism Coordinator
North Shore-Long Island Jewish Health System
New York
1:30 pm
Committee questions and discussion
1:50 pm
Decision analysis for antiviral distribution
Sinan Khan
Epidemiology Analyst
Los Angeles County
Emergency Preparedness and Response Program
Telephone and web-based decision support and triage
Barry Wolcott
Associate Professor
Uniformed Services University of Health Sciences
2:30 pm
Questions from the committee and discussion
2:45 pm
Break
3:00 pm
Antiviral distribution planning
- The public-private sector interface
Rex Archer
Director
Kansas City Health Department
Missouri
Lisa Koonin
Senior Advisor
Influenza Coordination Unit
Coordinating Center for Infectious Diseases
Centers for Disease Control and Prevention
4:00 pm
- Perspectives from the private sector
Katherine B. Andrus
Assistant General Counsel
Air Transport Association of America, Inc.
Stephen Jones
Cluster Occupational Health Manager
Downstream and Chemicals
ExxonMobil Corporation
Michael McGuire
Vice President
Roche Laboratories Inc.
Committee questions and discussion
4:15 pm
Ethical principles in planning for the distribution of antiviral medication
Nancy Kass
Phoebe R. Berman Professor of Bioethics
and Public Health
Johns Hopkins University
Ethical framework in Minnesota’s plans for distribution of antiviral medication
Dorothy Vawter
Associate Director
Center for Health Care Ethics
Minnesota
4:45 pm
Committee questions and discussion
5:00
Antiviral distribution planning, continued
- In a publicly-funded health care system
Victoria Davey
Deputy Chief Public Health and
Environmental Hazards Officer
Veterans Health Administration
Department of Veterans Affairs
- Private health care system
Skip Skivington
Vice President of Operations, Procurement and Supply
Program Offices
Kaiser Permanente
Eric Koscove
Chief
Emergancy Department
Kaiser Permanente Medical Center
5:35 pm
Committee Questions and Discussion
5:50 pm
Public Comment (if time allows)
6:00 pm
Adjourn
Back to Meeting